BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 24266011)

  • 1. Prognostic factors following surgical resection of distal bile duct cancer.
    Chung YJ; Choi DW; Choi SH; Heo JS; Kim DH
    J Korean Surg Soc; 2013 Nov; 85(5):212-8. PubMed ID: 24266011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Significance of positive ductal margin and prognostic factors of surgical resection in middle and distal bile duct carcinoma].
    Liang JW; Zhao P; Zhou ZX; Tian YT; Zhao DB; Wang CF
    Zhonghua Wai Ke Za Zhi; 2009 May; 47(9):677-80. PubMed ID: 19615237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Factors for Distal Bile Duct Carcinoma After Surgery.
    Kawahara R; Midorikawa R; Taniwaki S; Kojima S; Kanno H; Yoshitomi M; Nomura Y; Goto Y; Satou T; Sakai H; Ishikawa H; Hisaka T; Yasunaga M; Sakaue T; Ushijima T; Yasumoto M; Okabe Y; Tanigawa M; Naitou Y; Yano H; Okuda K
    Kurume Med J; 2023 Jul; 68(2):81-89. PubMed ID: 37005293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pylorus-preserving pancreatoduodenectomy. Is it an adequate cancer operation.
    Tsao JI; Rossi RL; Lowell JA
    Arch Surg; 1994 Apr; 129(4):405-12. PubMed ID: 7908796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic comparison of the longitudinal margin status in distal bile duct cancer: R0 on first bile duct resection versus R0 after additional resection.
    Park Y; Hwang DW; Kim JH; Hong SM; Jun SY; Lee JH; Song KB; Jun ES; Kim SC; Park KM
    J Hepatobiliary Pancreat Sci; 2019 May; 26(5):169-178. PubMed ID: 30849218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carcinoma of the distal and middle bile duct: surgical results, prognostic factors, and long-term follow-up.
    Bahra M; Jacob D; Langrehr JM; Neumann UP; Neuhaus P
    J Hepatobiliary Pancreat Surg; 2008; 15(5):501-7. PubMed ID: 18836804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival Comparison of Different Operation Types for Middle Bile Duct Cancer: Bile Duct Resection versus Pancreaticoduodenectomy Considering Complications and Adjuvant Treatment Effects.
    Lim SY; Alramadhan HJ; Jeong H; Chae H; Kim HS; Yoon SJ; Shin SH; Han IW; Heo JS; Kim H
    Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38254787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival outcome and prognostic factors after pancreatoduodenectomy for distal bile duct carcinoma: a retrospective multicenter study.
    Petrova E; Rückert F; Zach S; Shen Y; Weitz J; Grützmann R; Wittel UA; Makowiec F; Hopt UT; Bronsert P; Kühn F; Rau BM; Izrailov RE; Khatkov IE; Lapshyn H; Bolm L; Bausch D; Keck T; Wellner UF; Seifert G
    Langenbecks Arch Surg; 2017 Aug; 402(5):831-840. PubMed ID: 28612115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors for radical resection of middle and distal bile duct cancer.
    Nomura T; Tsuchiya Y; Nashimoto A; Yabusaki H; Takii Y; Nakagawa S; Sato N; Kanbayashi C; Tanaka O
    Hepatogastroenterology; 2009; 56(90):294-8. PubMed ID: 19579585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic indicators following curative pancreatoduodenectomy for pancreatic carcinoma: A retrospective multivariate analysis of a single centre experience.
    Petrou A; Soonawalla Z; Silva MA; Manzelli A; Moris D; Tabet PP; Friend P
    J BUON; 2016; 21(4):874-882. PubMed ID: 27685908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors after pancreatoduodenectomy for distal bile duct cancer.
    Qiao QL; Zhang TP; Guo JC; Zhan HX; Zhao JX; Liu YC; Wan YL; Leng XS; Zhao YP
    Am Surg; 2011 Nov; 77(11):1445-8. PubMed ID: 22196654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical value of additional resection of a margin-positive distal bile duct in perihilar cholangiocarcinoma.
    Otsuka S; Ebata T; Yokoyama Y; Mizuno T; Tsukahara T; Shimoyama Y; Ando M; Nagino M
    Br J Surg; 2019 May; 106(6):774-782. PubMed ID: 30889275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of relapse and long-term survival between pylorus-preserving and Whipple pancreaticoduodenectomy in periampullary cancer.
    Takao S; Aikou T; Shinchi H; Uchikura K; Kubo M; Imamura H; Maenohara S
    Am J Surg; 1998 Nov; 176(5):467-70. PubMed ID: 9874435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors after pancreatoduodenectomy with extended lymphadenectomy for distal bile duct cancer.
    Yoshida T; Matsumoto T; Sasaki A; Morii Y; Aramaki M; Kitano S
    Arch Surg; 2002 Jan; 137(1):69-73. PubMed ID: 11772220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The survival outcome and prognostic factors for middle and distal bile duct cancer following surgical resection.
    Choi SB; Park SW; Kim KS; Choi JS; Lee WJ
    J Surg Oncol; 2009 May; 99(6):335-42. PubMed ID: 19226533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors of surgical resection in middle and distal bile duct cancer: an analysis of 55 patients concerning the significance of ductal and radial margins.
    Sakamoto Y; Kosuge T; Shimada K; Sano T; Ojima H; Yamamoto J; Yamasaki S; Takayama T; Makuuchi M
    Surgery; 2005 Apr; 137(4):396-402. PubMed ID: 15800484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreaticoduodenectomy for secondary periampullary cancer following extrahepatic bile duct cancer resection.
    Kim DH; Choi DW; Choi SH; Heo JS
    Ann Surg Treat Res; 2014 Aug; 87(2):94-9. PubMed ID: 25114889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic impact of neutrophil-to-lymphocyte ratio (NLR) and lymphocyte-to-monocyte ratio (LMR) in patients with distal bile duct cancer.
    Miyahara Y; Takashi S; Shimizu Y; Ohtsuka M
    World J Surg Oncol; 2020 Apr; 18(1):78. PubMed ID: 32321522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreatoduodenectomy for bile duct and ampullary cancer.
    Yamaguchi K
    J Hepatobiliary Pancreat Sci; 2012 May; 19(3):210-5. PubMed ID: 22170385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical strategy for bile duct cancer: Advances and current limitations.
    Akamatsu N; Sugawara Y; Hashimoto D
    World J Clin Oncol; 2011 Feb; 2(2):94-107. PubMed ID: 21603318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.